The serum levels of Mcp1 of the NASH-HFD group were 2.1-fold higher than those of the HL-HFD group; however, there were no statistically significant differences between groups HL-STD and NASH-STD. The gene discussed is CCL2; the disease is metabolic dysfunction-associated steatohepatitis.